Barry Iacopetta

Transferrin receptors and iron uptake during erythroid cell development.

B. Iacopetta, G. Yeoh, E. Morgan, 1982, Biochimica et biophysica acta.

A new cause for CA19.9 elevation: heavy tea consumption

F. Al-Mulla, M. Sbai-Idrissi, O. Marty, 2003, Gut.

A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

B. Iacopetta, H. Elsaleh, D. Joseph, 2001, British Journal of Cancer.

Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.

B. Iacopetta, H. Elsaleh, Barry Iacopetta, 2001, Clinical colorectal cancer.

Heme inhibits transferrin endocytosis in immature erythroid cells.

B. Iacopetta, E. Morgan, Barry Iacopetta, 1984, Biochimica et biophysica acta.

Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.

B. Iacopetta, B. Powell, R. Soong, 2000, European journal of cancer.

p53 alterations are associated with improved prognosis in distal colonic carcinomas.

R. Parsons, B. Iacopetta, R. Soong, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients

B. Iacopetta, L. Fritschi, C. Platell, 2007, British Journal of Cancer.

Population‐based study of prognostic factors in stage II colonic cancer

B. Iacopetta, K. McCaul, C. Platell, 2006, The British journal of surgery.

Low expression of γ-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype

G. Watanabe, K. Kawakami, B. Iacopetta, 2008, British Journal of Cancer.

Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas.

B. Iacopetta, R. Soong, P. Robbins, 1996, Human pathology.